Treace Medical Concepts (TMCI) Inventory (2020 - 2026)

Treace Medical Concepts has reported Inventory for 7 years, with the latest figure at $36.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 4.15% year-over-year to $36.4 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (down 4.15% YoY), and the FY2025 full-year result was $36.0 million, down 8.21% from the prior year.
• Inventory for Q1 2026 stood at $36.4 million, up from $36.0 million in the prior quarter.
• The five-year high for Inventory was $43.6 million in Q3 2024, with the low at $11.1 million in Q1 2022.
• Historically, Inventory has averaged $30.7 million across 5 years, with a median of $35.9 million in 2024.
• Annual changes were most pronounced in 2023 — Inventory soared 102.65% — and 2025, when it declined 8.21%.
• Treace Medical Concepts' Inventory stood at $19.3 million in 2022, then surged by 51.29% to $29.2 million in 2023, then surged by 34.23% to $39.3 million in 2024, then dropped by 8.21% to $36.0 million in 2025, then rose by 0.93% to $36.4 million in 2026.
• The last three Inventory figures came in at $36.4 million (Q1 2026), $36.0 million (Q4 2025), and $41.4 million (Q3 2025), per Business Quant data.